Death domain containing receptor 4
US6902910B2 · kind B2 · utility
9Cited by
13References
91Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 21, 2002 |
| Grant date | Jun 7, 2005 |
| Priority date | — |
| Expiry date | Mar 29, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.